Bioprocess Development Forum - Insights, Solutions, and Shortcuts in Bioprocessing
BioPharm
Sponsored by Cytiva
Biopharma Trends
Upstream
Downstream
Regulatory/QbD
Articles
Subscribe to Enews
Share This Page
Email
Facebook
Twitter
July 28, 2022
Do Modeling and Simulation Tools Really Benefit the Biosimilar Industry?
BioPharm
The business impact of modeling and simulation tools is not well understood and requires clarification of their benefits to drug development.
READ THE FULL ARTICLE >>
Related Content
Cell-Culture Advances Test Bioreactor Performance Models
Free eBook: Considerations for smarter and faster process development
Chromatography Modeling Days: Learn from the downstream modeling community
Simulation gets therapies to patients faster and smarter
Increase Efficiency in Experimentation with Design of Experiments
See All Articles…